Overview
PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.
Eligibility
Inclusion Criteria:
- Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction
- Ability for participant to comply with study requirements
- Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities
- Written informed consent
Exclusion Criteria:
- Present STEMI
- Pregnant or breastfeeding
- Having an active atrial fibrillation episode as seen on most current 12-lead ECG
- Active thoracic metal implant
- Poor access to follow-up